http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-108413-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_940e1f8479ac5bf42c2ea2652763176a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
filingDate 2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-108413-A1
titleOfInvention METHODS OF TREATMENT OF MYELODISPLASSIC SYNDROME WITH INHIBITORS OF FARNESILTRANSFERASA
abstract Claim 1: A method of treating myelodysplastic syndrome (MDS) in a subject, characterized in that it comprises the administration of a therapeutically effective amount of a farnesyltransferase inhibitor (FTI) to said subject, wherein said subject is characterized by Th1 prevalence. Claim 35: The method according to claim 34, characterized in that the FTI is tipifarnib.
priorityDate 2016-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412425184

Total number of triples: 26.